Skip to main content
. 2025 Apr 11;19(3):427–437. doi: 10.5009/gnl240584

Table 4.

Risk of Cirrhosis-Related Complications According to MELD3.0 within the Enrollment of the First 3 Months

MELD3.0 p-value
<10 (n=628) 10 to <20 (n=1,694) ≥ 20 (n=992)
Cirrhosis-related complication, No. (%) 98 (15.6) 449 (26.5) 323 (32.6) <0.001
New onset or uncontrolled ascites 75 (11.9) 346 (20.4) 155 (25.9) <0.001
Gastroesophageal varix bleeding 27 (4.3) 102 (6.0) 41 (4.1) 0.058
Hepatorenal syndrome 0 (0.0) 2 (0.1) 18 (1.8) <0.001
Hepatic encephalopathy 3 (0.5) 45 (2.7) 58 (5.9) <0.001

MELD3.0, Model for End-Stage Liver Disease 3.0.